The PI3K/Akt/mTOR signaling pathway affects the tumor cell cycle, apoptosis, autophagy, and angiogenesis by altering the activity of its downstream effector molecules, and therefore, it may be an effective tool for targeted cancer therapy. Here, AKT1 is linked to cancer.